Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia
Cecilie Marie Nielsen, Pernille Kølbæk, David E. Dines, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 11, pp. 1208-1217
Closed Access | Times Cited: 9

Showing 9 citing articles:

COSMIN systematic review and meta-analysis of the measurement properties of the PANSS-6
Simon Geck, Maximilian Roithmeier, Markus Bühner, et al.
European Neuropsychopharmacology (2025) Vol. 94, pp. 41-50
Open Access | Times Cited: 2
Comparing PANSS-6 and PANSS-30 for clinical and functional outcomes in first-episode psychosis: A 2-year follow-up in a Spanish cohort
Vicent Llorca-Bofí, Marina Garriga, Gisela Mezquida, et al.
European Neuropsychopharmacology (2025) Vol. 95, pp. 9-13
Closed Access
Initial severity of the Positive and Negative Syndrome Scale (PANSS)-30, its main subscales plus the PANSS-6, and the relationship to subsequent improvement and trial dropout: a pooled participant-level analysis of 18 placebo-controlled risperidone and paliperidone trials
Fredrik Hieronymus, Christoph U. Correll, Søren Dinesen Østergaard
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Risperidone ISM®: review and update of its usefulness in all phases of schizophrenia
Thomas Messer, Miquel Bernardo, Lourdes Anta, et al.
Therapeutic Advances in Psychopharmacology (2024) Vol. 14
Open Access | Times Cited: 2
Structural validity of the 5-item World Health Organization Well-being Index (WHO-5) in patients with schizophrenia spectrum disorders
Cecilie Marie Nielsen, Henrik Hein Lauridsen, Søren Dinesen Østergaard, et al.
Journal of Psychiatric Research (2023) Vol. 170, pp. 387-393
Closed Access | Times Cited: 3
A review on the current status of homoeopathy in the management of schizophrenia
Sreeja Kudukayil Radhakrishnan Nair Kudukayil
International Journal of High Dilution Research - ISSN 1982-6206 (2023) Vol. 22, Iss. cf, pp. 92-104
Open Access | Times Cited: 1
Medication burden reduction and early clinical benefit through aripiprazole once monthly in schizophrenia patients with polypharmacy
Jiwan Moon, Hyeryun Yang, Sra Jung, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 135, pp. 111115-111115
Closed Access
The Transdiagnostic Global Impression - Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice
Christoph U. Correll, Z.B. Dombi, Ágota Barabássy, et al.
European Neuropsychopharmacology (2024) Vol. 88, pp. 31-39
Open Access
Are informants required to obtain valid ratings on the Positive and Negative Syndrome Scale (PANSS)?
Cecilie Marie Nielsen, Pernille Kølbæk, David E. Dines, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access
Page 1

Scroll to top